Skip to main content
Presentation
Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. 10th Annual Rheumatology Winter Clinical Symposium (RWCS), Maui, Hawaii, Feb 2017.
10th Annual Rheumatology Winter Clinical Symposium (RWCS) (2017)
  • Philip Mease, Providence St. Joseph Health
  • et.al.
Disciplines
Publication Date
February, 2017
Citation Information
Philip Mease and et.al.. "Long-term (Up to 156 Weeks) Safety Profile of Oral Apremilast in Patients With Psoriatic Arthritis: Pooled Analysis of PALACE 1-3. 10th Annual Rheumatology Winter Clinical Symposium (RWCS), Maui, Hawaii, Feb 2017." 10th Annual Rheumatology Winter Clinical Symposium (RWCS) (2017)
Available at: http://works.bepress.com/philip-mease/295/